- Home
- LYV vs ONC Comparison
LYV vs ONC Comparison
Compare LYV & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LYV | ONC |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.3B | 34.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LYV | ONC |
|---|---|---|
| Price | $157.89 | $355.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 12 |
| Target Price | $174.70 | ★ $370.25 |
| AVG Volume (30 Days) | ★ 2.7M | 231.8K |
| Earning Date | 02-19-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.87 | N/A |
| EPS | ★ 1.38 | 0.58 |
| Revenue | ★ $24,569,494,000.00 | $4,972,687,000.00 |
| Revenue This Year | $9.14 | $895.40 |
| Revenue Next Year | $9.24 | $22.04 |
| P/E Ratio | ★ $114.86 | $591.66 |
| Revenue Growth | 5.48 | ★ 50.43 |
| 52 Week Low | $112.88 | $196.45 |
| 52 Week High | $175.25 | $385.22 |
Technical Indicators
Market Signals| Indicator | LYV | ONC |
|---|---|---|
| Relative Strength Index (RSI) | 66.88 | 58.20 |
| Support Level | $136.42 | $342.00 |
| Resistance Level | $159.89 | $358.38 |
| Average True Range (ATR) | 4.82 | 10.23 |
| MACD | 1.50 | -0.43 |
| Stochastic Oscillator | 90.11 | 82.73 |
Price Performance
Historical ComparisonAbout LYV Live Nation Entertainment Inc.
Live Nation is the largest live entertainment company in the world, serving as a concert promoter, venue operator, and ticketing platform. In addition, the firm generates revenue from sponsorships and advertising. With offices in 45 countries, Live Nation promotes concerts globally and it owned, operated, or had exclusive booking rights to nearly 400 venues worldwide at the end of 2024, which the firm says makes it the second-largest operator of music venues globally. In 2024, Live Nation promoted nearly 55,000 events, drawing more than 150 million fans. Ticketmaster is a dominant global ticketing service, selling almost 640 million tickets in 2024.
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.